Aurion Biotech (AURN US)

Analysis

Health Care • United States

Aurion Biotechnologies operates as a clinical-stage biotechnology company. The Company focuses on developing life-changing regenerative therapies. Aurion Biotechnologies serves customers in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00